{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:57:51Z","timestamp":1762459071606},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T00:00:00Z","timestamp":1358467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00737-013-0327-1","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T00:13:05Z","timestamp":1358381585000},"page":"131-137","source":"Crossref","is-referenced-by-count":33,"title":["Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder"],"prefix":"10.1007","volume":"16","author":[{"given":"Birgitta","family":"Segebladh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elin","family":"Bannbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Moby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Bixo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torbj\u00f6rn","family":"B\u00e4ckstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger","family":"Sundstr\u00f6m Poromaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,18]]},"reference":[{"key":"327_CR1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.psyneuen.2004.07.003","volume":"30","author":"L Andreen","year":"2005","unstructured":"Andreen L, Sundstrom-Poromaa I, Bixo M, Andersson A, Nyberg S, Backstrom T (2005) Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology 30:212\u2013224","journal-title":"Psychoneuroendocrinology"},{"key":"327_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00213-006-0417-0","volume":"187","author":"L Andreen","year":"2006","unstructured":"Andreen L, Sundstrom-Poromaa I, Bixo M, Nyberg S, Backstrom T (2006) Allopregnanolone concentration and mood\u2014a bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology (Berl) 187:209\u2013221","journal-title":"Psychopharmacology (Berl)"},{"key":"327_CR3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1196\/annals.1286.005","volume":"1007","author":"T Backstrom","year":"2003","unstructured":"Backstrom T, Andersson A, Andree L, Birzniece V, Bixo M, Bjorn I et al (2003) Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci 1007:42\u201353","journal-title":"Ann N Y Acad Sci"},{"key":"327_CR4","doi-asserted-by":"crossref","unstructured":"Backstrom T, Bixo M, Nyberg S, Savic I (2012) Increased neurosteroid sensitivity\u2014an explanation to symptoms associated with chronic work related stress in women? Psychoneuroendocrinology","DOI":"10.1016\/j.psyneuen.2012.10.014"},{"key":"327_CR5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0033291700020407","volume":"21","author":"J Bancroft","year":"1991","unstructured":"Bancroft J, Cook A, Davidson D, Bennie J, Goodwin G (1991) Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol Med 21:305\u2013312","journal-title":"Psychol Med"},{"key":"327_CR6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0006-3223(98)00403-X","volume":"43","author":"M Bloch","year":"1998","unstructured":"Bloch M, Schmidt PJ, Su TP, Tobin MB, Rubinow DR (1998) Pituitary-adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls. Biol Psychiatry 43:897\u2013903","journal-title":"Biol Psychiatry"},{"key":"327_CR7","doi-asserted-by":"crossref","unstructured":"Brown J, OB PM, Marjoribanks J, Wyatt K (2009) Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev CD001396","DOI":"10.1002\/14651858.CD001396.pub2"},{"key":"327_CR8","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S1734-1140(10)70365-0","volume":"62","author":"B Budziszewska","year":"2010","unstructured":"Budziszewska B, Zajac A, Basta-Kaim A, Leskiewicz M, Steczkowska M, Lason W et al (2010) Effects of neurosteroids on the human corticotropin-releasing hormone gene. Pharmacol Rep 62:1030\u20131040","journal-title":"Pharmacol Rep"},{"key":"327_CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1677\/joe.0.1580121","volume":"158","author":"AE Calogero","year":"1998","unstructured":"Calogero AE, Palumbo MA, Bosboom AM, Burrello N, Ferrara E, Palumbo G et al (1998) The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the gamma-aminobutyric acid A receptor. J Endocrinol 158:121\u2013125","journal-title":"J Endocrinol"},{"key":"327_CR10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0006-8993(97)00749-X","volume":"766","author":"C Corpechot","year":"1997","unstructured":"Corpechot C, Collins BE, Carey MP, Tsouros A, Robel P, Fry JP (1997) Brain neurosteroids during the mouse oestrous cycle. Brain Res 766:276\u2013280","journal-title":"Brain Res"},{"key":"327_CR11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/10673220902891836","volume":"17","author":"J Cunningham","year":"2009","unstructured":"Cunningham J, Yonkers KA, O'Brien S, Eriksson E (2009) Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry 17:120\u2013137","journal-title":"Harv Rev Psychiatry"},{"key":"327_CR12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archpsyc.59.9.851","volume":"59","author":"CN Epperson","year":"2002","unstructured":"Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W et al (2002) Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59:851\u2013858","journal-title":"Arch Gen Psychiatry"},{"key":"327_CR13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/00365510510025773","volume":"65","author":"AH Garde","year":"2005","unstructured":"Garde AH, Hansen AM (2005) Long-term stability of salivary cortisol. Scand J Clin Lab Invest 65:433\u2013436","journal-title":"Scand J Clin Lab Invest"},{"key":"327_CR14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2007.05.006","volume":"116","author":"SS Girdler","year":"2007","unstructured":"Girdler SS, Klatzkin R (2007) Neurosteroids in the context of stress: implications for depressive disorders. Pharmacol Ther 116:125\u2013139","journal-title":"Pharmacol Ther"},{"key":"327_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-1781(98)00074-2","volume":"81","author":"SS Girdler","year":"1998","unstructured":"Girdler SS, Pedersen CA, Straneva PA, Leserman J, Stanwyck CL, Benjamin S et al (1998) Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder. Psychiatry Res 81:163\u2013178","journal-title":"Psychiatry Res"},{"key":"327_CR16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0006-3223(00)01044-1","volume":"49","author":"SS Girdler","year":"2001","unstructured":"Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL (2001) Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49:788\u2013797","journal-title":"Biol Psychiatry"},{"key":"327_CR17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.PSY.0000088593.38201.CD","volume":"65","author":"SS Girdler","year":"2003","unstructured":"Girdler SS, Sherwood A, Hinderliter AL, Leserman J, Costello NL, Straneva PA et al (2003) Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. Psychosom Med 65:849\u2013856","journal-title":"Psychosom Med"},{"key":"327_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09513599509160184","volume":"9","author":"AL Guo","year":"1995","unstructured":"Guo AL, Petraglia F, Criscuolo M, Ficarra G, Nappi RE, Palumbo MA et al (1995) Evidence for a role of neurosteroids in modulation of diurnal changes and acute stress-induced corticosterone secretion in rats. Gynecol Endocrinol 9:1\u20137","journal-title":"Gynecol Endocrinol"},{"key":"327_CR19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jama.284.5.592","volume":"284","author":"C Heim","year":"2000","unstructured":"Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R et al (2000) Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. Jama 284:592\u2013597","journal-title":"Jama"},{"key":"327_CR20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1176\/appi.ajp.158.4.575","volume":"158","author":"C Heim","year":"2001","unstructured":"Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB (2001) Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 158:575\u2013581","journal-title":"Am J Psychiatry"},{"key":"327_CR21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pscychresns.2006.05.002","volume":"148","author":"H Jovanovic","year":"2006","unstructured":"Jovanovic H, Cerin A, Karlsson P, Lundberg J, Halldin C, Nordstrom AL (2006) A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Res 148:185\u2013193","journal-title":"Psychiatry Res"},{"key":"327_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.biopsycho.2010.01.018","volume":"84","author":"RR Klatzkin","year":"2010","unstructured":"Klatzkin RR, Lindgren ME, Forneris CA, Girdler SS (2010) Histories of major depression and premenstrual dysphoric disorder: evidence for phenotypic differences. Biol Psychol 84:235\u2013247","journal-title":"Biol Psychol"},{"key":"327_CR23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1196\/annals.1296.057","volume":"1018","author":"KJ Kovacs","year":"2004","unstructured":"Kovacs KJ, Miklos IH, Bali B (2004) GABAergic mechanisms constraining the activity of the hypothalamo-pituitary-adrenocortical axis. Ann N Y Acad Sci 1018:466\u2013476","journal-title":"Ann N Y Acad Sci"},{"key":"327_CR24","first-page":"47","volume":"27","author":"RD Levitan","year":"2002","unstructured":"Levitan RD, Vaccarino FJ, Brown GM, Kennedy SH (2002) Low-dose dexamethasone challenge in women with atypical major depression: pilot study. J Psychiatry Neurosci 27:47\u201351","journal-title":"J Psychiatry Neurosci"},{"key":"327_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09513590310001652955","volume":"18","author":"I Lombardi","year":"2004","unstructured":"Lombardi I, Luisi S, Quirici B, Monteleone P, Bernardi F, Liut M et al (2004) Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Gynecol Endocrinol 18:79\u201387","journal-title":"Gynecol Endocrinol"},{"key":"327_CR26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mce.2005.04.007","volume":"239","author":"U Ottander","year":"2005","unstructured":"Ottander U, Poromaa IS, Bjurulf E, Skytt A, Backstrom T, Olofsson JI (2005) Allopregnanolone and pregnanolone are produced by the human corpus luteum. Mol Cell Endocrinol 239:37\u201344","journal-title":"Mol Cell Endocrinol"},{"key":"327_CR27","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0006-3223(00)00876-3","volume":"48","author":"BL Parry","year":"2000","unstructured":"Parry BL, Javeed S, Laughlin GA, Hauger R, Clopton P (2000) Cortisol circadian rhythms during the menstrual cycle and with sleep deprivation in premenstrual dysphoric disorder and normal control subjects. Biol Psychiatry 48:920\u2013931","journal-title":"Biol Psychiatry"},{"key":"327_CR28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0306-4522(94)90330-1","volume":"62","author":"VK Patchev","year":"1994","unstructured":"Patchev VK, Shoaib M, Holsboer F, Almeida OF (1994) The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 62:265\u2013271","journal-title":"Neuroscience"},{"key":"327_CR29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0893-133X(96)00096-6","volume":"15","author":"VK Patchev","year":"1996","unstructured":"Patchev VK, Hassan AH, Holsboer DF, Almeida OF (1996) The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15:533\u2013540","journal-title":"Neuropsychopharmacology"},{"key":"327_CR30","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4088\/JCP.v65n1004","volume":"65","author":"A Perkonigg","year":"2004","unstructured":"Perkonigg A, Yonkers KA, Pfister H, Lieb R, Wittchen HU (2004) Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder. J Clin Psychiatry 65:1314\u20131322","journal-title":"J Clin Psychiatry"},{"key":"327_CR31","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/jcem-71-5-1158","volume":"71","author":"DS Rabin","year":"1990","unstructured":"Rabin DS, Schmidt PJ, Campbell G, Gold PW, Jensvold M, Rubinow DR et al (1990) Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome. J Clin Endocrinol Metab 71:1158\u20131162","journal-title":"J Clin Endocrinol Metab"},{"key":"327_CR32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1530\/acta.0.1280536","volume":"128","author":"E Redei","year":"1993","unstructured":"Redei E, Freeman EW (1993) Preliminary evidence for plasma adrenocorticotropin levels as biological correlates of premenstrual symptoms. Acta Endocrinol (Copenh) 128:536\u2013542","journal-title":"Acta Endocrinol (Copenh)"},{"key":"327_CR33","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1210\/jc.2002-021570","volume":"88","author":"CA Roca","year":"2003","unstructured":"Roca CA, Schmidt PJ, Altemus M, Deuster P, Danaceau MA, Putnam K et al (2003) Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 88:3057\u20133063","journal-title":"J Clin Endocrinol Metab"},{"key":"327_CR34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/jwh.2008.1210","volume":"19","author":"C Sadler","year":"2010","unstructured":"Sadler C, Smith H, Hammond J, Bayly R, Borland S, Panay N et al (2010) Lifestyle factors, hormonal contraception, and premenstrual symptoms: the United Kingdom Southampton Women\u2019s Survey. J Womens Health (Larchmt) 19:391\u2013396","journal-title":"J Womens Health (Larchmt)"},{"key":"327_CR35","doi-asserted-by":"crossref","first-page":"139.e1","DOI":"10.1016\/j.ajog.2009.03.016","volume":"201","author":"B Segebladh","year":"2009","unstructured":"Segebladh B, Borgstrom A, Nyberg S, Bixo M, Sundstrom-Poromaa I (2009) Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Am J Obstet Gynecol 201:139.e1\u2013139.e8","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 20","key":"327_CR36","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22\u201333, quiz 34\u201357","journal-title":"J Clin Psychiatry"},{"key":"327_CR37","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1210\/jc.82.4.1220","volume":"82","author":"TP Su","year":"1997","unstructured":"Su TP, Schmidt PJ, Danaceau M, Murphy DL, Rubinow DR (1997) Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 82:1220\u20131228","journal-title":"J Clin Endocrinol Metab"},{"key":"327_CR38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00737-002-0147-1","volume":"6","author":"I Sundstrom Poromaa","year":"2003","unstructured":"Sundstrom Poromaa I, Smith S, Gulinello M (2003) GABA receptors, progesterone and premenstrual dysphoric disorder. Arch Women Ment Health 6:23\u201324","journal-title":"Arch Women Ment Health"},{"key":"327_CR39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/j.1600-0412.1999.781011.x","volume":"78","author":"I Sundstrom","year":"1999","unstructured":"Sundstrom I, Nyberg S, Bixo M, Hammarback S, Backstrom T (1999) Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Acta Obstet Gynecol Scand 78:891\u2013899","journal-title":"Acta Obstet Gynecol Scand"},{"key":"327_CR40","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00213-005-0148-7","volume":"186","author":"E Timby","year":"2006","unstructured":"Timby E, Balgard M, Nyberg S, Spigset O, Andersson A, Porankiewicz-Asplund J et al (2006) Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl) 186:414\u2013424","journal-title":"Psychopharmacology (Berl)"},{"key":"327_CR41","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/j.1460-9568.2004.03610.x","volume":"20","author":"S Turkmen","year":"2004","unstructured":"Turkmen S, Lundgren P, Birzniece V, Zingmark E, Backstrom T, Johansson IM (2004) 3beta-20beta-dihydroxy-5alpha-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone. Eur J Neurosci 20:1604\u20131612","journal-title":"Eur J Neurosci"},{"key":"327_CR42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/abio.2000.4841","volume":"287","author":"M Vallee","year":"2000","unstructured":"Vallee M, Rivera JD, Koob GF, Purdy RH, Fitzgerald RL (2000) Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography\/mass spectrometry. Anal Biochem 287:153\u2013166","journal-title":"Anal Biochem"},{"key":"327_CR43","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/jc.81.3.1076","volume":"81","author":"M Wang","year":"1996","unstructured":"Wang M, Seippel L, Purdy RH, Backstrom T (1996) Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 81:1076\u20131082","journal-title":"J Clin Endocrinol Metab"},{"key":"327_CR44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0033291701004925","volume":"32","author":"HU Wittchen","year":"2002","unstructured":"Wittchen HU, Becker E, Lieb R, Krause P (2002) Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32:119\u2013132","journal-title":"Psychol Med"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-013-0327-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00737-013-0327-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-013-0327-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T07:28:10Z","timestamp":1562570890000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00737-013-0327-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,18]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1007\/s00737-013-0327-1","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"value":"1434-1816","type":"print"},{"value":"1435-1102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,18]]}}}